Varian Medical Systems EPS
Was ist das EPS von Varian Medical Systems?
EPS von Varian Medical Systems, Inc. ist 3.03
Was ist die Definition von EPS?
Der Gewinn pro Aktie (EPS) ist der Anteil des Gewinns eines Unternehmens, der jeder im Umlauf befindlichen Stammaktie zugewiesen wird. Es wird der Verdünnung angepasst und über letzten zwölf Monate nachgerechnet.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu Varian Medical Systems
Was macht Varian Medical Systems?
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Unternehmen mit eps ähnlich Varian Medical Systems
- IHS Markit Ltd hat EPS von 3.03
- Foley Trasimene Acquisition hat EPS von 3.03
- The Goodyear Tire & Rubber hat EPS von 3.03
- Andersons hat EPS von 3.03
- Arcosa Inc hat EPS von 3.03
- Capital City Bank hat EPS von 3.03
- Varian Medical Systems hat EPS von 3.03
- ALD SA hat EPS von 3.04
- Adecco AG hat EPS von 3.04
- The Southern hat EPS von 3.04
- Leonardo DRS hat EPS von 3.04
- ASA International PLC hat EPS von 3.04
- SAF-HOLLAND SA hat EPS von 3.04